drugset / Trial / NCT07179952

Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )

NCT07179952 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

There is evidence to suggest that DHEA-based treatment could be beneficial to patients with asthma, yet one of the main treatments for asthma (taking glucocorticoids, a hormone that is effective in reducing inflammation), suppresses the production of DHEA. In this study, the investigators want to test and evaluate the safety of DHEA-based treatment.

Timeline

Start
2027-01-01
Primary completion
2028-09-30
Completion
2028-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator DHEA Unknown — —

Indications